Hrt Financial LP Isoray, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
N/A
101,895 Added 502.64%
122,167 $84,000
Q4 2023

Feb 09, 2024
SELL
N/A
-82,436 Reduced 80.26%
20,272 $8,000
Q3 2023

Nov 13, 2023
BUY
N/A
102,708 New
102,708 $28,000
Q4 2022

Feb 10, 2023
BUY
$0.24 - $0.4 $7,245 - $12,075
30,189 New
30,189 $7,000
Q1 2021

May 17, 2021
SELL
$0.53 - $2.47 $33,360 - $155,474
-62,945 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$0.36 - $0.58 $15,962 - $25,716
44,339 Added 238.3%
62,945 $28,000
Q3 2020

Nov 13, 2020
BUY
$0.54 - $0.78 $10,047 - $14,512
18,606 New
18,606 $10,000

Others Institutions Holding ISR

# of Institutions
2
Shares Held
145K
Call Options Held
0
Put Options Held
0
View Full List

About Isoray, Inc.

ISR Quotes by TradingView
  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email